Mechanisms of Action in IBS-C Therapies: Secretagogues and Serotonergic Agents
Mechanisms of Action in IBS-C Therapies: Secretagogues and Serotonergic Agents
Managing Treatment-Resistant IBS-C: Strategies to Address Refractory Symptoms
Managing Treatment-Resistant IBS-C: Strategies to Address Refractory Symptoms
Addressing Underlying Factors in IBS-C: A Multifaceted Treatment Approach
Addressing Underlying Factors in IBS-C: A Multifaceted Treatment Approach
The Burden of IBS-C: Uncovering Quality-of-Life Impacts
The Burden of IBS-C: Uncovering Quality-of-Life Impacts
Improving IBS-C Outcomes Through Personalized Treatment
Improving IBS-C Outcomes Through Personalized Treatment
Personalized Care in IBS-C: Empowering Patients Through Education and Self-Management
Personalized Care in IBS-C: Empowering Patients Through Education and Self-Management
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
May 04, 2025
09:30 PM - 10:30 PM ET
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Acute Kidney Injury in Cirrhosis: Multidisciplinary Decision-Making
Acute Kidney Injury in Cirrhosis: Multidisciplinary Decision-Making
Preparing the Patient with Decompensated Cirrhosis for Liver Transplant: ICU Discussions, Considerations and Dialysis
Preparing the Patient with Decompensated Cirrhosis for Liver Transplant: ICU Discussions, Considerations and Dialysis
Evaluation and Management of AKI in Cirrhosis: At the Interface of Gastroenterology and Nephrology
Evaluation and Management of AKI in Cirrhosis: At the Interface of Gastroenterology and Nephrology
Objective Measures and Endoscopic Improvement
Objective Measures and Endoscopic Improvement
Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
